News
The pharma giant has almost doubled the size of its workforce over the last five years but is now looking to tighten cost ...
GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...
The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.
As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar ...
It faces more than 1,800 lawsuits consolidated in federal court in Pennsylvania and new claims emerging weekly, according to ...
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
Novo Nordisk, the Denmark-based pharmaceutical company that makes Ozempic and Wegovy, looks like it's being toppled off its ...
Novo Nordisk, the company behind the blockbuster drugs Ozempic and Wegovy, said Wednesday it would pause ... Job growth has decelerated this year, and major employers, including T. Rowe Price Group ...
European stocks fell Thursday as investors weighed ongoing concerns about the artificial-intelligence boom and data showing gains in business activity. The composite purchasing managers' index for the ...
Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...
Festivities are underway at the USTA Billie Jean King National Tennis Center in Queens, so TODAY’s Dylan Dreyer surprises two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results